Details.
The UC San Diego Gene Therapy Initiative's 2026 Symposium brings together academic, industry, investor, regulatory, and legal leaders to discuss the future of cell and gene therapy, including ex vivo and in vivo genetic therapy technologies, rare disease treatments, AAV gene therapy, commercialization considerations, and bench-to-bedside strategies. Karen Potter will participate as a panelist in “Navigating Bench to Bedside.”